Division of Plastic and Reconstructive Surgery, University of Pittsburg Medical Center, Pittsburg Medical Center, Pittsburg, PA, USA.
J Am Acad Orthop Surg. 2010 Mar;18(3):127-31. doi: 10.5435/00124635-201003000-00001.
Recent advances in transplant immunology are shifting the focus from immunosuppression to immunoregulation, making composite tissue allotransplantation with novel and less potent immunosuppressive regimens a possibility. Hand transplantation has been the most frequently performed human composite tissue allotransplantation, with more than 50 upper extremity-based transplants done worldwide. Further research is needed regarding immunomodulating protocols, and careful oversight and individualized screening procedures will be required as patients seeking improved quality of life through human composite tissue allotransplantation come to accept a certain level of risk in these experimental procedures. Still, composite tissue allotransplantation offers to advance transplant medicine and reconstructive surgery.
移植免疫学的最新进展正在将焦点从免疫抑制转向免疫调节,使得使用新型、低强度免疫抑制方案进行复合组织同种异体移植成为可能。手移植是最常进行的人类复合组织同种异体移植,全世界已经完成了 50 多例以上的上肢移植。关于免疫调节方案还需要进一步的研究,随着寻求通过人类复合组织同种异体移植提高生活质量的患者接受这些实验性手术的一定程度的风险,需要仔细的监督和个体化的筛选程序。尽管如此,复合组织同种异体移植还是为移植医学和重建外科的发展提供了帮助。